No abstract

Both interventions are promising treatments. Consistent with previous controlled trials, MDFT is distinguished by the sustainability of treatment effects.

In the present article we have attempted to construct a model for predicting success and failure in the behavioral treatment (exposure and response prevention) of obsessive-compulsives. Three sets of variables, demographic, pretreatment level of neurotic symptomatology, and patient's responses during exposure sessions, were examined. Seven variables were found to be related to outcome at posttreatment and/or at follow-up: Pretreatment level of depression and of anxiety, reactivity, and habituation of reported anxiety to feared stimuli within-and between-sessions were all found to affect outcome at posttreatment. Posttreatment outcome as well as age at symptom onset were significantly related to maintenance of gains. A model of the interrelationships of these variables was constructed and tested by a path analysis. Implications of the model for enhancing treatment effects are discussed.

BackgroundDiabetes self-management education has been shown to be effective in controlled trials. The 6-week Better Choices, Better Health-Diabetes (BCBH-D) self-management program was also associated with an improvement in health outcomes in a 6-month translation study.ObjectiveThe objective of this study was to determine whether a national translation of the BCBH-D self-management program, offered both Web-based and face-to-face, was associated with improvements in health outcomes (including HbA1c) and health behaviors (including recommended medical tests) 1 year after interventionMethodsWeb-based programs were administered nationally, whereas face-to-face workshops took place in Atlanta, Indianapolis, and St Louis. Self-report questionnaires were either Web-based or administered by mail, at baseline and 1 year, and collected health and health-behavior measures. HbA1c blood samples were collected via mailed kits. A previous 6-month study found statistically significant improvements in 13 of 14 outcome measures, including HbA1c. For this study, paired t test compared baseline with 1-year outcomes. Subgroup analyses determined whether participants with specific conditions improved (high HbA1c, depression, hypoglycemia, nonadherence to medication, no aerobic exercise). The percentage of participants with improvements in effect size of at least 0.4 in at least 1 of the 5 measures was calculated.ResultsA total of 857 participants with 1-year data (69.7% of baseline participants) demonstrated statistically significant 1-year improvements in 13 of 15 outcome measures; 79.9% (685/857) of participants showed improvements in effect size of 0.4 or greater in at least 1 of the 5 criterial measures.ConclusionsParticipants had small but significant benefits in multiple measures. Improvements previously noted at 6 months were maintained or amplified at 1 year.

No abstract